Designed with input from electrophysiologists from around the world, the system creates highly detailed three-dimensional maps of the heart to help physicians identify and then treat areas of the heart where abnormal rhythms originate. and across Europe that is designed to help physicians better treat abnormal heart rhythms, also known as cardiac arrhythmias. ![]() ![]() Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform available in the U.S. 12, 2022 /PRNewswire/ - Abbott (NYSE: ABT) today announced it has received clearance from the U.S. ![]() FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms - EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromiseĪBBOTT PARK, Ill., Jan. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart RhythmsĪbbott Receives U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |